A global suppressor motif for p53 cancer mutants
- 22 March 2004
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (14) , 4930-4935
- https://doi.org/10.1073/pnas.0401162101
Abstract
The transcription factor and tumor suppressor protein p53 is frequently inactivated in human cancers. In many cases, p53 gene mutations result in high levels of inactive, full-length p53 protein with one amino acid change in the core domain that recognizes p53 DNA-binding sites. The ability to endow function to mutated p53 proteins would dramatically improve cancer therapy, because it would reactivate a central apoptotic pathway. By using genetic strategies and p53 assays in yeast and mammalian cells, we identified a global suppressor motif involving codons 235, 239, and 240. These intragenic suppressor mutations, either alone or in combination, restored function to 16 of 30 of the most common p53 cancer mutants tested. The 235-239-240 suppressor motif establishes that manipulation of a small region of the core domain is sufficient to activate a large number of p53 cancer mutants. Understanding the structural basis of the rescue mechanism will allow the pursuit of small compounds able to achieve a similar stabilization of p53 cancer mutants.Keywords
This publication has 31 references indexed in Scilit:
- Crystal Structure of a Superstable Mutant of Human p53 Core DomainJournal of Biological Chemistry, 2004
- Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sitesOncogene, 2002
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002
- Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assayOncogene, 2001
- Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutantsOncogene, 2001
- Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapyOncogene, 2000
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993